The Immune System – News and Features

The technology, based on the process of electroporation, uses extremely short electrical field pulses to temporarily open cell.

If RNAi is going to be viable as a therapy for organ-wide diseases such as hepatitis B or C, it will have to stick around.

Screening program will utilize Invitrogen's SelectScreen™ platform

Employing nanoengineered molecules called “nanolipoblockers” as frontline infantry against harmful cholesterol, is showing promise in early laboratory studies.

A team of scientists has published a new study of important signaling pathways that are required for the expansion of pancreas stem cells.

Researcher team at Baylor Research Institute plans to use the ProteomicProcessor™ to measure serum protein levels.

The rights Inovio has licensed include two patents with broad claims regarding electroporation of nucleic acids in muscle.

Findings show treatment with anti-C5 complement antibody reduced airway inflammation when used with standard nebulizer.

Stem cell lines derived directly from human glioblastoma brain tumors are a better model to study the biology and physiology of glioblastomas.

Biovest is now eligible to submit a biologics license application (BLA) on a rolling basis.